Education
About Us
Working with TipRanks
Follow Us
Mayne Pharma Group (AU:MYX)
ASX:MYX
MYX Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$3.74 - AU$7.46
Previous CloseN/A
Volume149.18K
Average Volume (3M)692.14K
Market Cap
$566.28M
Enterprise ValueAU$269.89M
Total Cash (Recent Filing)AU$30.38M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta0.29
Next Earnings
Aug 21, 2025EPS Estimate
<0.01Last Dividend Ex-Date
Jan 18, 2023Dividend YieldN/A
Share Statistics
EPS (TTM)-1.59
Shares Outstanding81,245,830
10 Day Avg. Volume621,003
30 Day Avg. Volume692,145
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.03
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$7.41Price Target Upside3.59% Upside
Rating ConsensusHold
Number of Analyst Covering2
---
Mayne Pharma Group News
PremiumCompany Announcements
State Street Corporation Ceases Substantial Holding in Mayne Pharma
PremiumCompany Announcements
State Street Corporation Becomes Substantial Holder in Mayne Pharma
PremiumCompany Announcements
UBS Reduces Stake in Mayne Pharma Group
PremiumCompany Announcements
UBS Increases Stake in Mayne Pharma GroupPremiumCompany Announcements
Insignia Financial Ltd Reduces Stake in Mayne Pharma Group
PremiumCompany Announcements
Mayne Pharma Group Ceases Substantial Holding
PremiumCompany Announcements
UBS Group AG Acquires Substantial Stake in Mayne Pharma
PremiumCompany Announcements
Mitsubishi UFJ Financial Group Increases Stake in Mayne Pharma---
Options Prices
Currently, No data available
---
Ownership Overview
0.07% Insiders
3.20%
Mutual Funds
<0.01% Other Institutional Investors
94.81% Public Companies and
Individual Investors
MYX FAQ
What was Mayne Pharma Group’s price range in the past 12 months?
Mayne Pharma Group lowest share price was AU$3.74 and its highest was AU$7.46 in the past 12 months.
What is Mayne Pharma Group’s market cap?
Mayne Pharma Group’s market cap is $566.28M.
When is Mayne Pharma Group’s upcoming earnings report date?
Mayne Pharma Group’s upcoming earnings report date is Aug 21, 2025 which is in 133 days.
How were Mayne Pharma Group’s earnings last quarter?
Mayne Pharma Group released its earnings results on Feb 25, 2025. The company reported -AU$0.253 earnings per share for the quarter, missing the consensus estimate of -AU$0.125 by -AU$0.128.
Is Mayne Pharma Group overvalued?
According to Wall Street analysts Mayne Pharma Group’s price is currently Undervalued.
Does Mayne Pharma Group pay dividends?
Mayne Pharma Group pays a Notavailable dividend of AU$0.027 which represents an annual dividend yield of N/A. See more information on Mayne Pharma Group dividends here
What is Mayne Pharma Group’s EPS estimate?
Mayne Pharma Group’s EPS estimate is <0.01.
How many shares outstanding does Mayne Pharma Group have?
Mayne Pharma Group has 81,245,830 shares outstanding.
What happened to Mayne Pharma Group’s price movement after its last earnings report?
Mayne Pharma Group reported an EPS of -AU$0.253 in its last earnings report, missing expectations of -AU$0.125. Following the earnings report the stock price went up 0.139%.
Which hedge fund is a major shareholder of Mayne Pharma Group?
Currently, no hedge funds are holding shares in AU:MYX
---
Mayne Pharma Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
AU$7.41 (3.59% Upside)
AU$7.41 (3.59% Upside)
Blogger Sentiment
Bullish
AU:MYX Sentiment 81%
Sector Average 69%
Sector Average 69%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-10.44%
12-Months-Change
Fundamentals
Return on Equity
-23.92%
Trailing 12-Months
Asset Growth
-11.07%
Trailing 12-Months
Company Description
Mayne Pharma Group
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products. It provides oral drug delivery systems; and contract pharmaceutical development, manufacturing, and analytical services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.
---
MYX Company Deck
---
MYX Earnings Call
Q2 2025
0:00 / 0:00
---
MYX Stock 12 Month Forecast
Average Price Target
AU$7.41
▲(3.59% Upside)
Technical Analysis
Sigma Healthcare Ltd
―
Ansell
―
CSL
―
Sonic Healthcare Limited
―
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
―
Best Analysts Covering MYX
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+37.90%
reiterated a buy rating 4 months ago
Copying Shane Storey's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +37.90% per trade.
---